ACRS SCHEDULE 13G/A: SEC filing
Filed with the SEC on · accession 0000929638-26-004367
ACRS filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -8.0% by the first close after the filing.
Summary of the filing
Biosion, Inc. and its wholly owned subsidiary Bonita Biotech (HK) Limited filed an amended Schedule 13G reporting beneficial ownership of 7,521,300 shares, or 4.7%, of Aclaris Therapeutics common stock, a passive investment position.
Key details
How ACRS stock reacted
Close before
$3.92
Nov 13, 2026
First close after
-8.04%
$3.60
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for ACRS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ACRS?
Click hereFrequently asked questions
What did ACRS file with the SEC on Nov 16, 2026?
ACRS filed a SCHEDULE 13G/A (SEC filing). Biosion, Inc. and its wholly owned subsidiary Bonita Biotech (HK) Limited filed an amended Schedule 13G reporting beneficial ownership of 7,521,300 shares, or 4.7%, of Aclaris Therapeutics common stock, a passive investment position.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did ACRS stock react to this filing?
ACRS closed at $3.92 before the filing and $3.60 on Nov 16, 2026 (-8.04%).
Other ACRS SEC filings
- 10-Q · SEC filingNov 5, 2026
- 8-K · SEC filingNov 5, 2026
- 8-K · Fda approvalOct 27, 2026
- 424B5 · Secondary offeringOct 27, 2026
- 8-K · SEC filingOct 27, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 8-K · Material agreementAug 6, 2026
- 8-K · SEC filingAug 6, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · Board changeJun 4, 2026
Get alerts when ACRS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days